Vaidya Sane Ayurved Laboratories Stock Screener | Share Price & Fundamental Analysis
MADHAVBAUG
Medical Equipment
Track Vaidya Sane Ayurved Laboratories share price live with TickJournal's free stock screener.
Analyze Vaidya Sane Ayurved Laboratories share price history trends and compare 52-week high low
levels.
Calculate MADHAVBAUG stock fair value using fundamental analysis and view live share price charts.
Determine Vaidya Sane Ayurved Laboratories share intrinsic value and compare it with current MADHAVBAUG share price.
Record your Vaidya Sane Ayurved Laboratories trades in TickJournal's free trading journal and track your portfolio performance.
Vaidya Sane Ayurved Laboratories Market Cap
₹227.30 Cr.
EPS (TTM)
₹1.88
Dividend Yield
-
Debt to Equity
0.02
Vaidya Sane Ayurved Laboratories 52 Week Low
-
Operating Margin
5.00%
Profit Margin
4.54%
MADHAVBAUG Revenue (TTM)
₹5,173.00
EBITDA
₹332.00
Net Income
₹235.00
Total Assets
₹71.00
Total Equity
₹56.00
Vaidya Sane Ayurved Laboratories Share Price History - Stock Screener Chart
Screen MADHAVBAUG historical share price movements with interactive charts. Analyze price trends and patterns.
Vaidya Sane Ayurved Laboratories Company Profile - Fundamental Screener
Screen Vaidya Sane Ayurved Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for MADHAVBAUG shares.
Sector
Healthcare
Industry
Medical Equipment
Sub-Sector
Medical Equipment
Segment
E
ISIN
INE0JR301013
Vaidya Sane Ayurved Laboratories Balance Sheet Screener
Screen MADHAVBAUG balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2024 | 2023 |
|---|---|---|
| Assets | ||
| Total Assets | 71 | 55 |
| Current Assets | 34 | 28 |
| Fixed Assets | 28 | 21 |
| Liabilities | ||
| Total Liabilities | 0 | 0 |
| Current Liabilities | 1 | 2 |
| Non-Current Liabilities | 0 | 0 |
| Shareholders' Equity | ||
| Total Equity | 56 | 41 |
| Share Capital | 11 | 11 |
| Reserves & Surplus | 32 | 30 |
Vaidya Sane Ayurved Laboratories Income Statement Screener - Profit & Revenue Analysis
Screen Vaidya Sane Ayurved Laboratories income statement and profit fundamentals.
Analyze MADHAVBAUG quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Vaidya Sane Ayurved Laboratories share price evaluation.
| Item | 2023-Sept | 2023-Jun | 2022-Sept |
|---|---|---|---|
| Revenue | 5,173 | 4,641 | 10,053 |
| Expenses | 4,842 | 4,142 | 9,131 |
| EBITDA | 332 | 500 | 922 |
| Operating Profit % | 5.00% | 9.00% | 8.00% |
| Depreciation | 159 | 116 | 260 |
| Interest | 16 | 11 | 19 |
| Profit Before Tax | 157 | 373 | 643 |
| Tax | -78 | 126 | -323 |
| Net Profit | 235 | 247 | 967 |
| EPS | 1.12 | 2.60 | 4.60 |
Vaidya Sane Ayurved Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen MADHAVBAUG cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2024-March | 2023-March |
|---|---|---|
| Operating Activities | -4 | 0 |
| Investing Activities | 2 | 1 |
| Financing Activities | 15 | -1 |
| Net Cash Flow | 12 | -1 |
Vaidya Sane Ayurved Laboratories Shareholding Pattern Screener
See Vaidya Sane Ayurved Laboratories shareholding pattern with promoter, FII, and DII holdings.
Check Vaidya Sane Ayurved Laboratories promoter holding and ownership changes for MADHAVBAUG on TickJournal.
| Item | 2025-Dec | 2025-Sept | 2025-Mar | 2024-Sept | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 66.34% | 66.34% | 66.34% | 66.34% | 66.34% | 66.34% | 66.34% | 66.34% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 21.63% | 21.80% | 21.94% | 22.24% | 22.69% | 22.31% | 22.92% | 23.90% |
| Other Holding | 12.03% | 11.86% | 11.72% | 11.43% | 10.97% | 11.35% | 10.74% | 9.76% |
| Shareholder Count | 700 | 712 | 787 | 821 | 881 | 846 | 731 | 637 |
Vaidya Sane Ayurved Laboratories Share Dividend Screener - Share Yield Analysis
Check Vaidya Sane Ayurved Laboratories dividend history with payout and yield data.
View Vaidya Sane Ayurved Laboratories dividend details including ex-dates and amounts for MADHAVBAUG stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.25 | 0.14% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Vaidya Sane Ayurved Laboratories Stock Index Membership
See which indices include Vaidya Sane Ayurved Laboratories stock.
Check MADHAVBAUG index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Vaidya Sane Ayurved Laboratories Market Events Screener - Corporate Actions
Get Vaidya Sane Ayurved Laboratories corporate actions including splits, bonuses, and buybacks.
Check Vaidya Sane Ayurved Laboratories stock events that may affect MADHAVBAUG share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 0.25 /share | 37.01% | ||
| Annual General Meeting | NA | -1.37% | ||
| 2025-11-05 | 2025-11-05 | Quarterly Result Announcement | NA | -0.53% |
| 2025-08-25 | 2025-08-25 | Extraordinary General Meeting | NA | 23.93% |
| 2025-05-22 | 2025-05-22 | Quarterly Result Announcement | NA | 5.65% |
| 2024-11-11 | 2024-11-11 | Quarterly Result Announcement | NA | 12.48% |
| 2022-11-18 | 2022-11-18 | Dividend | ₹ 0.25 /share | 6.63% |
Vaidya Sane Ayurved Laboratories Competitors Screener - Peer Comparison
Screen MADHAVBAUG competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Poly Medicure | 12,732 | 36.74 | 1,759 | 22.62% | 339 | 32.49 |
| Laxmi Dental | 1,058 | 45.52 | 242 | 24.12% | 25 | 42.66 |
| Tarsons Products | 1,015 | 50.46 | 408 | 32.64% | 30 | 39.54 |
| Osel Devices | 904 | 44.66 | 187 | 40.62% | 20 | 54.31 |
| Vasa Denticity | 779 | 59.53 | 173 | % | 15 | 30.31 |
| Fabtech Technologies | 667 | 21.83 | 336 | 45.66% | 47 | 33.43 |
| Prevest Denpro | 543 | 27.38 | 67 | 13.15% | 18 | 47.40 |
| Hemant Surgical Industries | 383 | 47.49 | 112 | % | 8 | 53.48 |
| Aprameya Engineering | 376 | 24.56 | 136 | 107.77% | 16 | 29.54 |
| Nureca | 295 | 26.72 | 122 | 19.24% | 1 | 54.15 |
Vaidya Sane Ayurved Laboratories Company Announcements - News Screener
Screen MADHAVBAUG latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.